Yan Li

6.2k total citations
260 papers, 4.2k citations indexed

About

Yan Li is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yan Li has authored 260 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Molecular Biology, 47 papers in Oncology and 34 papers in Cancer Research. Recurrent topics in Yan Li's work include Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (10 papers) and Breast Cancer Treatment Studies (8 papers). Yan Li is often cited by papers focused on Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (10 papers) and Breast Cancer Treatment Studies (8 papers). Yan Li collaborates with scholars based in China, United States and United Kingdom. Yan Li's co-authors include Shujuan Sun, Lars Hansen, W. James Cook, Nayyar Iqbal, Julio Rosenstock, Boaz Hirshberg, Urban Lindgren, Göran Andersson, Xu He and Jinlong Yu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Yan Li

245 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Li China 32 1.6k 688 534 493 487 260 4.2k
Peter Kružliak Czechia 39 1.7k 1.0× 386 0.6× 491 0.9× 360 0.7× 454 0.9× 221 5.0k
Angela Lombardi Italy 35 2.1k 1.3× 476 0.7× 518 1.0× 660 1.3× 346 0.7× 109 4.7k
Fuu‐Jen Tsai Taiwan 35 1.6k 1.0× 450 0.7× 463 0.9× 225 0.5× 315 0.6× 275 4.2k
Ying Xin China 37 2.9k 1.8× 707 1.0× 420 0.8× 380 0.8× 603 1.2× 235 5.7k
Roberto Bei Italy 40 2.0k 1.2× 1.0k 1.5× 552 1.0× 355 0.7× 411 0.8× 154 5.1k
Masaki Kobayashi Japan 35 1.6k 1.0× 972 1.4× 267 0.5× 209 0.4× 519 1.1× 276 5.0k
Zuyi Yuan China 37 1.7k 1.1× 533 0.8× 665 1.2× 557 1.1× 375 0.8× 240 5.3k
Mingyue Zhou China 26 1.7k 1.1× 616 0.9× 464 0.9× 561 1.1× 274 0.6× 80 4.1k
Cheng Zhang China 39 2.3k 1.4× 389 0.6× 625 1.2× 303 0.6× 518 1.1× 184 4.6k
Masato Maekawa Japan 33 1.6k 1.0× 604 0.9× 335 0.6× 190 0.4× 441 0.9× 222 3.9k

Countries citing papers authored by Yan Li

Since Specialization
Citations

This map shows the geographic impact of Yan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Li more than expected).

Fields of papers citing papers by Yan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Li. The network helps show where Yan Li may publish in the future.

Co-authorship network of co-authors of Yan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Li. A scholar is included among the top collaborators of Yan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Li. Yan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Juan, Liuqing Huang, Yan Li, et al.. (2024). Development of receptor-targeted and pH-responsive zeolitic imidazole framework-90 nanoplatform for anti-ovarian cancer. Inorganic Chemistry Communications. 167. 112715–112715.
2.
3.
Zhou, Xingtong, Mohan Liu, Zhibo Zheng, et al.. (2024). Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population‐based study. Cancer. 130(S8). 1464–1475. 2 indexed citations
4.
Zhu, Ping, Yan Li, Ting Guo, et al.. (2023). New antifungal strategies: Drug combination and co-delivery. Advanced Drug Delivery Reviews. 198. 114874–114874. 31 indexed citations
5.
Tan, Xueyun, Sufei Wang, Hebing Chen, et al.. (2023). Prognosis prediction of icotinib as targeted therapy for advanced EGFR-positive non–small cell lung cancer patients. Investigational New Drugs. 41(3). 463–472. 2 indexed citations
6.
Li, Xingyu, Xuan Wang, Yaping Guan, et al.. (2023). Clinical characteristics and management of immune checkpoint inhibitor-related cardiotoxicity: A single-center experience. Frontiers in Cardiovascular Medicine. 10. 1093383–1093383. 10 indexed citations
7.
Li, Yan, Jie Wang, Lu Lu, et al.. (2023). CD44 targeting nanodrug based on chondroitin sulfate for melanoma therapy by inducing mitochondrial apoptosis pathways. Carbohydrate Polymers. 320. 121255–121255. 21 indexed citations
8.
Li, Yan, et al.. (2023). Interference with XPO1 Suppresses the Stemness and Radioresistance of CD44 Positive Cervical Cancer Cells via Binding with Rad21.. PubMed. 53(2). 278–292. 1 indexed citations
9.
Liu, Kunyi, Rui Zhang, Botao Wu, et al.. (2022). Risk factors for emergency endoscopic variceal ligation treatment failure of acute variceal bleeding. Scandinavian Journal of Gastroenterology. 57(12). 1509–1516. 2 indexed citations
10.
Tang, Bo‐Hao, et al.. (2022). Effect of drug combination on tacrolimus target dose in renal transplant patients with different CYP3A5 genotypes. Xenobiotica. 52(3). 312–321. 3 indexed citations
11.
12.
Duan, Tao, et al.. (2019). Effects of melatonin implantation on carcass characteristics, meat quality and tissue levels of melatonin and prolactin in Inner Mongolian cashmere goats. Journal of Animal Science and Biotechnology. 10(1). 70–70. 16 indexed citations
13.
Liu, Qinggang, Zonglong Wu, Yaxiao Liu, et al.. (2019). Cannabinoid receptor 2 activation decreases severity of cyclophosphamide‐induced cystitis via regulating autophagy. Neurourology and Urodynamics. 39(1). 158–169. 31 indexed citations
14.
15.
Huang, Xin, Qian Dong, Guo‐Xiang Hao, et al.. (2017). Determination of cefoperazone and sulbactam in serum by HPLC‐MS/MS: An adapted method for therapeutic drug monitoring in children. Biomedical Chromatography. 32(4). 11 indexed citations
16.
Li, Yan, et al.. (2017). Chloroplast genome structure and variation analysis of Brassicaceae species.. Xibei zhiwu xuebao. 37(6). 1090–1101. 3 indexed citations
17.
Andrade, Mariza de, Yan Li, Randolph S. Marks, et al.. (2011). Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer. Cancer Prevention Research. 5(3). 365–373. 19 indexed citations
18.
Cao, Yanyan, Hui Ming Ge, Longqi Chen, et al.. (2007). [Correlation of 53BP1 and p53 polymorphisms to susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].. PubMed. 26(10). 1052–7. 10 indexed citations
19.
Wang, Na, et al.. (2007). [Correlations of XRCC5 polymorphisms to genetic susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a high incidence region].. PubMed. 26(3). 280–4. 5 indexed citations
20.
Hu, Ming-Bai, Wei Xie, Dingfen Han, et al.. (2006). [Study on the relationship between polymorphisms of genes (CYP17, CYP19 and SULT1A1) and susceptibility to breast cancer in Chinese women].. PubMed. 27(4). 351–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Kružliak Breakdown of academic impact, for papers by Angela Lombardi Breakdown of academic impact, for papers by Fuu‐Jen Tsai Breakdown of academic impact, for papers by Ying Xin Breakdown of academic impact, for papers by Roberto Bei Breakdown of academic impact, for papers by Masaki Kobayashi Breakdown of academic impact, for papers by Zuyi Yuan Breakdown of academic impact, for papers by Mingyue Zhou Breakdown of academic impact, for papers by Cheng Zhang Breakdown of academic impact, for papers by Masato Maekawa
Rankless by CCL
2026